The active Hsc70/tau complex can be exploited to enhance tau turnover without damaging microtubule dynamics.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Human Molecular Genetics

• Publication date

  2015-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddv135PMID 25882706PMCID PMC4560066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hsp70-Bag3 interactions regulate cancer-related signaling networks.

  2014cited by this paper
• Hsp90 Chaperone Inhibitor 17-AAG Attenuates Aβ-Induced Synaptic Toxicity and Memory Impairment

  2014cited by this paper
• Heat Shock Protein 70 Inhibitors. 2. 2,5′-Thiodipyrimidines, 5-(Phenylthio)pyrimidines, 2-(Pyridin-3-ylthio)pyrimidines, and 3-(Phenylthio)pyridines as Reversible Binders to an Allosteric Site on Heat Shock Protein 70

  2014cited by this paper
• Heat Shock Protein 70 Inhibitors. 1. 2,5′-Thiodipyrimidine and 5-(Phenylthio)pyrimidine Acrylamides as Irreversible Binders to an Allosteric Site on Heat Shock Protein 70

  2014cited by this paper
• Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer

  2014cited by this paper
• Microtubules and Their Role in Cellular Stress in Cancer

  2014cited by this paper
• Hsp90-Tau complex reveals molecular basis for specificity in chaperone action.

  2014cited by this paper
• Imbalance of Hsp70 family variants fosters tau accumulation

  2013cited by this paper
• Functional Analysis of Hsp70 Inhibitors

  2013cited by this paper
• Allosteric heat shock protein 70 inhibitors rapidly rescue synaptic plasticity deficits by reducing aberrant tau.

  2013cited by this paper
• Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy

  2013cited by this paper
• Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells

  2013cited by this paper
• Molecular mechanisms of Tau binding to microtubules and its role in microtubule dynamics in live cells

  2013cited by this paper
• Binding of Human Nucleotide Exchange Factors to Heat Shock Protein 70 (Hsp70) Generates Functionally Distinct Complexes in Vitro*

  2013cited by this paper
• Tau proteins expressions in advanced breast cancer and its significance in taxane-containing neoadjuvant chemotherapy

  2013cited by this paper
• Identification of an allosteric pocket on human hsp70 reveals a mode of inhibition of this therapeutically important protein.

  2013cited by this paper
• Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels.

  2013cited by this paper
• Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents.

  2013cited by this paper
• Structure and dynamics of the ATP-bound open conformation of Hsp70 chaperones.

  2012cited by this paper
• Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance

  2012cited by this paper
• Widespread Tau and Amyloid‐Beta Pathology Many Years After a Single Traumatic Brain Injury in Humans

  2012cited by this paper
• Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts

  2011cited by this paper
• Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones.

  2011cited by this paper
• 4-Hydroxyderricin from Angelica keiskei roots induces caspase-dependent apoptotic cell death in HL60 human leukemia cells.

  2011cited by this paper
• Brain-Permeable Small-Molecule Inhibitors of Hsp90 Prevent α-Synuclein Oligomer Formation and Rescue α-Synuclein-Induced Toxicity

  2010cited by this paper
• Hsc70 Rapidly Engages Tau after Microtubule Destabilization*

  2010cited by this paper
• Human microtubule-associated-protein tau regulates the number of protofilaments in microtubules: a synchrotron x-ray scattering study.

  2009cited by this paper
• Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability

  2009cited by this paper
• Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

  2009cited by this paper
• Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.

  2009cited by this paper
• Two motifs within the tau microtubule‐binding domain mediate its association with the hsc70 molecular chaperone

  2008cited by this paper
• A Microtubule Interactome: Complexes with Roles in Cell Cycle and Mitosis

  2008cited by this paper
• The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.

  2007cited by this paper
• Structural and microtubule binding properties of tau mutants of frontotemporal dementias.

  2007cited by this paper
• BAG3 regulates motility and adhesion of epithelial cancer cells.

  2007cited by this paper
• A non-toxic Hsp90 inhibitor protects neurons from Abeta-induced toxicity.

  2007cited by this paper
• Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.

  2007cited by this paper
• Staining protocol for organotypic hippocampal slice cultures

  2006cited by this paper
• Identification of proteins binding the native tubulin dimer.

  2005cited by this paper
• Pathways of chaperone-mediated protein folding in the cytosol

  2004cited by this paper
• Chaperones increase association of tau protein with microtubules

  2003cited by this paper
• Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease

  2003cited by this paper
• A constitutive 70 kDa heat-shock protein is localized on the fibres of spindles and asters at metaphase in an ATP-dependent manner: a new chaperone role is proposed.

  2001cited by this paper
• Treatment of ras-induced cancers by the F-actin-bundling drug MKT-077.

  2000cited by this paper
• Tubulin and Neurofilament Proteins Are Transported Differently in Axons of Chicken Motoneurons

  2000cited by this paper
• Multistep mechanism of substrate binding determines chaperone activity of Hsp70

  2000cited by this paper
• Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function.

  2000cited by this paper
• Constitutive hsp70 is essential to mitosis during early cleavage of Paracentrotus lividus embryos: the blockage of constitutive hsp70 impairs mitosis.

  1999cited by this paper
• Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly

  1998cited by this paper
• Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly.

  1997cited by this paper
• Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077.

  1996cited by this paper
• Research in Health Care

  1996cited by this paper
• MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation.

  1996cited by this paper
• Binding of heat-shock protein 70 (hsp70) to tubulin.

  1994cited by this paper
• Assembly and bundling of marginal band microtubule protein: role of tau.

  1994cited by this paper
• Structural basis of the 70-kilodalton heat shock cognate protein ATP hydrolytic activity. II. Structure of the active site with ADP or ATP bound to wild type and mutant ATPase fragment.

  1994cited by this paper
• hsp70 is localized to the centrosome of dividing HeLa cells.

  1991cited by this paper
• Identification of a protein altered in mutants resistant to microtubule inhibitors as a member of the major heat shock protein (hsp70) family

  1990cited by this paper
• A protein factor essential for microtubule assembly.

  1975cited by this paper

• Synaptic Chaperone Dysfunction as a Convergent Mechanism in Neurodegenerative and Psychiatric Disorders.

  2026cites this paper
• A novel lncRNA FAM151B-DT regulates autophagy and degradation of aggregation prone proteins

  2025cites this paper
• Design of multi-target peptide modulators for protein chaperone networks.

  2025cites this paper
• Tau protein aggregation: A therapeutic target for neurodegenerative diseases.

  2025cites this paper
• A novel lncRNA FAM151B-DT regulates degradation of aggregation prone proteins

  2025cites this paper
• The E3 Ubiquitin Ligase, CHIP/STUB1, Inhibits Aggregation of Phosphorylated Proteoforms of Microtubule-associated Protein Tau (MAPT).

  2023cites this paper
• DnaJs are enriched in tau regulators.

  2023cites this paper
• Benzothiazole Substitution Analogs of Rhodacyanine Hsp70 Inhibitors Modulate Tau Accumulation.

  2023cites this paper
• Hsc70-4 aggravates PolyQ-mediated neurodegeneration by modulating NF-κB mediated immune response in Drosophila

  2022cites this paper
• Inhibitors of heat shock protein 70 (Hsp70) with enhanced metabolic stability reduce tau levels.

  2021cites this paper
• The Hidden Side of NCAM Family: NCAM2, a Key Cytoskeleton Organization Molecule Regulating Multiple Neural Functions

  2021cites this paper
• Hsp40s play complementary roles in the prevention of tau amyloid formation

  2021cites this paper
• Mutant Ataxin-3–Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder

  2021cites this paper
• Aberrant AZIN2 and polyamine metabolism precipitates tau neuropathology.

  2021cites this paper
• Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake

  2020cites this paper
• Arginine π-stacking drives binding to fibrils of the Alzheimer protein Tau

  2020cites this paper
• Effects of Pyridoxine Deficiency on Hippocampal Function and Its Possible Association with V-Type Proton ATPase Subunit B2 and Heat Shock Cognate Protein 70

  2020cites this paper
• Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation

  2020cites this paper
• C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside

  2020cites this paper
• A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation

  2019cites this paper
• Tau Oligomers.

  2019cites this paper
• Fibril formation rewires interactome of the Alzheimer protein Tau by π-stacking

  2019cites this paper
• HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation

  2018cites this paper
• Human chaperones untangle fibrils of the Alzheimer protein Tau

  2018cites this paper
• Therapeutic Strategies for Restoring Tau Homeostasis.

  2018cites this paper
• Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes

  2017cites this paper
• Protein-Remodeling Factors As Potential Therapeutics for Neurodegenerative Disease

  2017cites this paper
• Engineering therapeutic protein disaggregases

  2016cites this paper
• Therapeutic strategies for the treatment of tauopathies: Hopes and challenges

  2016cites this paper
• Inhibition of Both Hsp70 Activity and Tau Aggregation in Vitro Best Predicts Tau Lowering Activity of Small Molecules.

  2016cites this paper
• DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative‐associated proteins

  2016influential citation
• Hallmarks of therapeutic management of the cystic fibrosis functional landscape.

  2015cites this paper